Improve balance through mental rehearsal

Trial ID
NCT07495462
Official Title
The Effect of Motor Imagery Added to Conventional Rehabilitation on Balance and Kinesiophobia in Patients With Parkinson's Disease: A Randomized Controlled Trial
Goal
Improve balance through mental rehearsal
Phase
NA
Status
RECRUITING
Sponsor
Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital
Study Type
INTERVENTIONAL
Enrollment
42 participants
Conditions
Parkinson Disease (PD)
Interventions
Conventional Rehabilitation, Motor Imagery Training

Summary For Families

The goal is to see whether adding motor imagery to regular rehab can improve balance and reduce kinesiophobia, the fear of moving that often limits activity in Parkinson's. Motor imagery training asks you to mentally rehearse specific movements to activate the same brain networks used for actual movement, which can strengthen motor planning and balance control without extra physical strain; it is given alongside conventional physical therapy and can be used with usual Parkinson's medications like levodopa, not as a replacement. They are enrolling people aged 40 and up with Parkinson's at Hoehn and Yahr stage 1 to 3 who can follow instructions, shown by an MMSE score of 22 or higher. People with deep brain stimulation, major motor fluctuations or severe dyskinesia, other neurologic disorders, significant orthopedic or cardiopulmonary limits, or visual/vestibular problems affecting balance are not eligible.

Locations

  • Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital, Istanbul, Istanbul, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Conventional Rehabilitation. The goal is to see whether adding motor imagery to regular rehab can improve balance and reduce kinesiophobia, the fear of moving that often limits activity in Parkinson's. Motor imagery training asks you to mentally rehearse specific movements to activate the same brain networks used for actual movement, which can strengthen motor planning and balance control without extra physical strain; it is given alongside conventional physical therapy and can be used with usual Parkinson's medications like levodopa, not as a replacement. They are enrolling people aged 40 and up with Parkinson's at Hoehn and Yahr stage 1 to 3 who can follow instructions, shown by an MMSE score of 22 or higher. People with deep brain stimulation, major motor fluctuations or severe dyskinesia, other neurologic disorders, significant orthopedic or cardiopulmonary limits, or visual/vestibular problems affecting balance are not eligible.
Who can participate?
Participants must be at least 40 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
No. There is no cost to participate. Study-related care and treatment are provided at no charge.
How long does the trial last?
This trial is estimated to last approximately 6 months.
Will I get the real drug or a placebo?
It depends on the trial design. Some Parkinson's trials are placebo controlled, meaning a portion of participants get an inactive comparison while others get the experimental treatment. Some use crossover designs so everyone eventually receives the active treatment at some point. Observational trials do not use a placebo at all because they are not testing a new treatment. The consent form for any specific trial spells out the design and your odds of being assigned to placebo before you enroll.
How often will I need to visit the study site?
Visit frequency varies by trial. Many Parkinson's studies require an in person visit every 4 to 12 weeks during the active treatment phase, with shorter or longer gaps depending on the design. The site coordinator can give you the full visit schedule before you sign anything, so you know what the time commitment looks like.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Will travel or parking be reimbursed?
Many trials reimburse for parking, mileage, and sometimes lodging if the site is far from your home. Reimbursement policies vary by sponsor and site. When you contact the trial team, ask specifically what is covered and how reimbursement is processed.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.

Related Reading

View on ClinicalTrials.gov